Single Port Surgical Platform Market grows with growing preference towards minimally invasive surgery process

Single port surgical platform (SPSP) is a minimal invasive laparoscopy technique in which, a single incision is made on the body through single trocar which have multiple ports or single skin incision site with multiple facial incisions that have an individual trocar, are used to conduct the surgery. Single port surgical platforms are also called Single Port Access Surgery (SPA), Single-Incision Laparoscopic Surgery (SILS), and Laparo-endoscopic Single-Site Surgery (LESS). Normally, in abdominal surgeries, large incisions are made to conduct the surgery. Although, they are effective but they usually cause postoperative pain, wound infections, and prolonged hospitalization. Current rate of incisional hernia is 4-18% and wound infections are 2-25% in the U.S whereas, in case of conventional laparoscopic surgeries, multiple incisions are made on the body to conduct the surgery. To overcome the above challenges, companies are focusing on developing the novel single-port surgical platform, which creates single incision on the body. This surgical platform also helps in speedy recovery, small incisions, and are less prone to infections and pain conditions. In addition to these, it does not leave any scars on the body after the surgery.

The market is driven mainly by factors such as technological innovations, increase in adoption of SPSP, growing preference towards minimally invasive surgery process, and exploration of their utility in other applications Ex: General Surgery, Gastroenterology, Urology, Gynecology and Bariatric Surgery. Increasing preference towards scar-less slimming surgeries is a major factor responsible for boosting the market growth. This platform allows surgeons to conduct surgeries in the abdominal cavity by accessing through small holes. Furthermore, SPSP reduces treatment costs by reducing hospital stay of the patients. Hence, patients and surgeons are prefer SPSP as compared to others. The major constraints of this market are high cost, lack of skilled professionals, and triangulation problems. The single port surgical platform (SPSP) is segmented based on its application and technology.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15263

Segmentation by Application

• General Surgery
• Gastroenterology
• Urological
• Gynecological
• Bariatric

Segmentation by Technology

• Robot/ Remote controlled Assisted
• Manual – Assisted

New products are being launched into the market to alleviate the disadvantages of the current SPSP platforms. SPSP is a lucrative segment in the laparoscopic surgeries, due to its technical aspects and patient benefits. On the basis of application, SPSP is mainly used in Bariatric surgeries. However, they are gaining traction of the other application areas such as gynecology, urology, gastroenterology, and general surgery due to its advantages.

On the basis of its technology, the manual assisted SPSP holds major market share as compared to robot-assisted. In future, robot/ remote controlled technology is expected to dominate the market because surgeons can perform the complex surgeries in a more accurate and flexible way than the conventional surgery process by using the robot/ remote controlled technology

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=15263

Recently, Intuitive surgical, a U.S.-based company, received FDA approval for its da Vinci Sp single port robot-assisted surgical system.

SPSP is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is holds a major market share on the basis of application of the SPSP owing to factors such as spending power of the people and introduction of new technologies into the market. Asia-Pacific markets are growing relatively fast due to cost effective surgeries and advancements in healthcare infrastructure.

Key players in this market are Covidien, Applied Medical, Ethicon, Olympus Gyrus-ACMI, Novare Surgical, Cambridge Endo, Karl Storz, Intutive surgical, Fortmedix Surgical, and Trans Enterix. The market is relatively dominated by major players however, new players are trying to hold a major part of the market share by developing innovative products.

Vacuum Assist Biopsy System Market - Worldwide Market Shares, Strategies, and Forecasts 2016 to 2024

In a Biopsy procedure tissue samples are taken for study and diagnosis of the suspicious lesions in the for cytology or histopathology studies. Breast biopsies are done through various techniques like Fine Needle Aspiration Biopsy, Core Needle Biopsy and Surgical Biopsies. Among which Fine Needle Aspiration Biopsies are the conventional ones. In case of Core Needle Biopsies tissue samples are collected through the core of the needle, this technique is currently used at many places. Vacuum Assist Biopsy is a type of core needle biopsy which uses Vacuum for collection of tissue sample. In Vacuum Assisted Biopsy the needle is introduced percutaneous to the lesion sight either by stereotactic or image assisted (Ultrasound or MRI) approach. Due to the clinical advantages of this technique for the sampling of nodular lesions, better samples combined with least procedure time, non-invasive, less scaring for patient Vacuum Assist Biopsy is gaining acceptance among the physicians. In this procedure the probe / core needle is inserted through skin under image assistance or stereotactic guidance to the lesion. One it reaches the lesion vacuum is applied which draws the lesion / tissue inside the core, after which the cutting device cuts it from the breast tissue by rotation. By repeating these steps multiple tissue samples could be collected. On required sample collection, radiologist / physician can take out the probe/needle and a small bandage can be placed on the insertion site. This procedure doesn’t need a sterile setup and is performed under local anesthesia. Due to the availability of large core probes/needles these systems are finding the place in removal of small benign lumps and resection of palpable or non-palpable breast lesions.

Read Full Report: http://www.transparencymarketresearch.com/vacuum-assist-biopsy-system-market.html

Global Market for Vacuum Assist Biopsy Systems can be segmented based on the technique used for Guiding or Positioning Technique, End User and Geography:

Segmentation based on Guiding Technique

• Stereotactic Vacuum Assist Biopsy System
• Image Guided Vacuum Assist Biopsy System

Segmentation Based on End User

• Hospitals
• Clinics
• Diagnostic Centers

Positioning and guiding of the probe / needle is the critical stage in any biopsy technique and for Vacuum Assist Biopsy it needs a skillful user. Based on the guiding technique these can be categorized into Stereotactic Vacuum Assist Biopsy Systems and Image Guided Vacuum Assist Biopsy System. For Stereotactic systems mammography is used as a reference for positioning the probe whereas image guided systems could be based on Ultrasound imaging or MRI. Among them Ultrasound guided systems are getting widely used and are having large acceptance in future. Due to some limitations like short availability of the procedure period window, difficulty in accessing the far lesions MRI guided systems got set back but with new developments they are getting acceptance for specialized procedures which are not possible with stereotactic and US guided techniques.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15191

As this procedure is non-invasive and is undertaken with local anesthesia, it doesn’t need a complete sterile environment and so can be done in mini operating rooms or physician’s office where the MRI Guided Vacuum Assist Biopsy System is a limitation. Due to the shorter procedure time and less complications involved these procedures are done on day care basis also. Based on the End User’s the market can be segmented into Hospitals, Clinics and Diagnostic Centers.

On the basis of regional presence, global Vacuum Assist Biopsy Systems market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Breast Cancer counts 25% of the lethal cancers female population face and overall it contributes to around 12% of the cancer cases in a year globally. In America it is estimated that around 12% of the female population with have the breast cancer in their lifetime. In UK and Belgium around 15% of breast cancer cased are diagnosed every year. As per studies females of age more than 45 Years are susceptible to breast cancer or some breast disease. Asia Pacific region comprising countries like Indian and Chine are among the most potential markets after North America and Europe due to growing population with mid or old age and rising awareness for healthcare.

Some of the major players in global Vacuum Assist Biopsy System market are C.R. Bard Inc. Devicor Medical Products Inc.(Leica Biosystems), Hologic Inc., Etc.

Corneal Implantable Devices Market: Trends, Opportunities and Forecasts 2024

Corneal Implants, also known as corneal inlays are optical devices that are inserted into the cornea to improve reading vision. The chief purpose of these optical devices is to improve near vision and reduce the need for reading spectacles in older adults who have presbyopia. It has been estimated that presbyopia affects nearly over 80-90% population over the age of 40 years worldwide. Corneal implantable devices are one of the options for rectification of decreased near vision in presbyopic people who desire to have spectacle-independent superior vision at all distances. Corneal implantable devices do not restore the ability to accommodate, however, they work by increasing the depth of focus or the refractive power of the central or paracentral part of the cornea. Corneal implantable devices have also been used for correction of hyperopia, myopia, and astigmatism. Adults who are in their middle age start experiencing symptoms of difficulty in reading and often are compelled to resort to wearing spectacles for the same. However, many people have an inherent stigma or dislike associated with wearing glasses since it is believed to hamper looks. Many people in their middle age often resort to procedures which would make them look younger than their age. Moreover it is inconvenient to carry a spectacle case around everywhere one goes. This consumer behavior, which is the personal preference by many to go spectacle-free shall drive the growth of the corneal implantable device market. Currently, commercially available corneal implantable devices include the Kamra Inlay, the Presbia Flexivue Microlens, the Raindrop Near Vision Inlay and the Icolens.

The market for corneal implantable devices has been segmented on the basis of type of implant, distribution channel and geography. Based on type of implant, the market has been segmented into refractive corneal implantable device, corneal reshaping implantable device and small aperture corneal implantable device. It has been estimated that presbyopia affects more than 1 billion people worldwide and since it affects almost all adults as they age, representing a large and continuous market of potential patients for these devices. In April 2015, the U.S. FDA approved the Kamra Corneal Inlay, the first small aperture corneal implantable device for correction of near vision in patients who have not had cataract surgery. Subsequently in June 2016, the U.S. FDA approved the Raindrop Near Vision Inlay, for the improvement of near vision in presbyopia patients. Due to the availability of the Kamra Inlay in 50 countries, and with approximately 20,000 corneal implants of the Kamra Inlay in a year since its launch, the market for small aperture corneal implantable devices is anticipated to grow at the highest CAGR during the forecast period.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16343

Based on distribution channel, the market has been segmented into hospitals, ophthalmic clinics, retail ophthalmic stores and online retail. The ophthalmic clinics segment is anticipated to witness high revenue share owing to a larger proportion of inpatient corneal implant procedures in these clinics and thus a greater demand for corneal implantable devices from this distribution channel.

Based on geography, the market has been segmented into the following regions: North America, Europe, Latin America, Asia Pacific, Latin America and Middle East and Africa. North America and Europe are expected to be the leading markets in the corneal implantable devices market, owing to larger awareness regarding corneal implants and greater patient adoption for the technique. According to the Office of National Statistics, in the UK, presently there are approximately 80% more people over the age of 65 than in the mid-twentieth century and, as their median age is likely to pass 40 in the near future, the number of people experiencing ocular aging is expected to increase too. Furthermore, it is estimated that there are over 209 million European population suffers from presbyopia and it is projected that by 2030, nearly half of Europe’s population will have presbyopia. This shall propel the market for corneal implantable devices in Europe during the forecast period. However, Asia Pacific represents a vast population with an unmet need in the domain of ocular ageing treatment. In Japan, it has been observed that youth in their 20’s and 30’s are witnessing presbyopia-like symptoms due to overuse of devices and technology such as smartphones. These demographic and lifestyle changes coupled with the highest number of aging population, is anticipated to bolster the corneal implantable devices market in Asia Pacific during the forecast period.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=16343

The market is dominated by few organizations and thus, the competition is intense. The major players operating in this market include ReVision Optics, Inc., Presbia., Neoptics AG and AcuFocus Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Positive Airway Pressure Devices Market - An insight on the important factors and trends influencing the market

Positive airway pressure devices keep pressured air flowing through the airways of the throat and is one of the common treatments for sleep apnea. The patient wears a face mask which is attached with a tube and a machine that blows pressurized air through the mask into the airway to keep it open. The air acts like a balloon holding the relaxed muscles of the throat open. Positive airway pressure (PAP) is a treatment method that uses mild air pressure to keep the airways sufficiently open. PAP devices are specially used by patients that have breathing issues, such as sleep apnea. These devices are broadly categorized as continuous positive airway pressure devices (CPAP), bi-level positive airway pressure (BiPAP), and automatic positive airway pressure devices (APAP). The growing prevalence of sleep apnea and co-morbidities related to PAP have propelled the use of positive airway pressure devices. The global positive airway pressure devices is anticipated to witness a trend of devices that are compact and comfortable through 2024.

Obstructive sleep apnea (OSA) is a chronic medical condition requiring night application of therapy to efficiently limit the number of apneas and hypopneas that would occur without intervention. The gold-standard treatment for OSA is continuous positive airway pressure therapy (PAP), which offers a pneumatic splint of the soft tissue in the upper airway. PAP devices can measure and record airflow and pressure levels whenever the device is worn. They contain internal, proprietary algorithms that identify breathing disturbances and whether these disturbances are due to persistent obstructive or non-obstructive events. Generally, the average duration of CPAP use is approximately five hours per night across numerous studies. Studies indicate that greater than six hours per night results in normal levels of objectively measured and self-reported daytime sleepiness, as well as significantly improved memory and daily functioning.

Variable positive airway pressure (VPAP) or bi-level positive airway pressure (BiPAP), is a newer type of machine that reduces the amount of pressure when a person breathes out. The device uses an electronic circuit to monitor the person's breathing. Having less pressure in the moment when a person is exhaling may make it more comfortable for the person with sleep apnea. This type of machine is used for people who have other breathing problems or who can't sleep if they have to breathe out against a stream of air.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16337

The U.S. accounted for the largest market share in positive airway pressure devices market. This is due to the increasing healthcare awareness for sleep apnea, improving healthcare infrastructure, rising disposable incomes, increasing obesity adding to the pool of sleep apnea patients and economic growth favored by broadening insurance coverage. Center for Medicare & Medicaid Services (CMS) provides cover for sleep apnea products, including a capped rental on CPAP/BiPAP equipment and other supplies. As per the Centers for Disease Control and Prevention (CDC), 36% of the adults in the U.S. were obese in 2010, and nearly 42% will be obese by the year 2030. Furthermore, according to National Sleep Foundation, in 2012, around 40 Mn Americans were reported to suffer from chronic sleep disorder.

Geographically, North America occupies the substantially larger market share, which is followed by Europe. The high attentiveness level in this region will lead the expansion of positive airway pressure devices market significantly. However, affordability has become a restraining factor for the global market in developing regions such as, Asia Pacific and Latin America. Asia Pacific is expected to demonstrate healthy CAGR in the global positive airway devices market. Increase in disposable income, rising aging population, and growing awareness level are some of the key factors driving the Asia Pacific market. The Asian market is expected to witness entry of higher number of new players compared to those in developed regions.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=16337

Some of the market players who are competing to bring new technologically advanced products in the market are CareFusion Corporation, GE Healthcare, Philips Healthcare, ResMed, Inc., Teleflex, Inc., and others

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Glenoid Implant System Market: Historical, current and projected market size in terms of volume and value

Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called Glenoid. Implanting the glenoid in a proper orientation is essential for long-term stability of the prosthesis. A malpositioned glenoid may have compromised fixation due to inadequate bony support or incomplete implant seating and may be subjected to increased torques on the fixation surface. The other causes for Glenoid implants are Osteoarthritis, Rheumatoid Arthritis, degenerative arthritis, Rotator Cuff Tear Arthroplasty, Avascular Necrosis, and Severe Fractures etc. According to the Agency for Healthcare Research and Quality, about 53,000 people in the U.S. have shoulder replacement surgery each year. Implantation of a glenoid component is not advised if the glenoid has good cartilage, the glenoid bone is severely deficient, and the rotator cuff tendons are irreparably torn. Glenoid Implants are available in different size, such as small, medium, large and XL. Glenoid involvement in degenerative arthritis varies depends on the type of arthritic process affecting the glenohumeral. For Instance, inflammatory arthritis is associated with central glenoid erosion. The extent and location of glenoid wear should be assessed preoperatively with axillary radiographs, axial CT scans and through the glenohumeral joint, or 3D CT reconstructions.

Read Full Report: http://www.transparencymarketresearch.com/glenoid-implant-system-market.html

Achieving long-term fixation of the glenoid is a primary goal in total shoulder arthroplasty. Several methods of fixation have been attempted, including cemented, noncemented, and hybrid or minimally cemented devices. Cemented pegged and keeled components are used most commonly and are provide the most predictable fixation. Noncemented glenoids rely upon mechanical interlock and biologic integration, typically by screw fixation or a combination of screw or press-fit pegs, or both, to achieve an initial fixation that facilitates long-term bone in-growth/on-growth. According to center of disease control and prevention the prevalence of diagnosed arthritis is expected to increase among US population in the coming decades. By the year 2040, an estimated 78 million adults aged 18 years and older will have diagnosed with arthritis, compared with the 52.5 million adults in 2010-2012.

Glenoid Implant System Market: Drivers and Restraints

Factors such as Growing prevalence of symptomatic shoulder arthritis, increased patient awareness, technological advancement and expanded medical education and surgeon adoption of total shoulder replacement will fuel the overall glenoid implant market globally. According to National Health Interview Survey, 22.7 million (9.8% of all adults) have arthritis and arthritis-attributable activity limitation. Factors such as glenoid component loosening, pricing pressure, improper handling of implants are the factors will hinder the total glenoid implant market globally. Glenoid loosening is associated with increased pain, decreased shoulder function, and the need for revision surgery.

Glenoid Implant Systems Market: Segmentation

The global Glenoid implant systems market is classified on the basis of product type, Size, end user and regional presence.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15236

Segmentation based on product type:

• Pegged Glenoids
• Keeled Glenoids

Segmentation based on Size:

• Small
• Medium
• Large
• XL

Segmentation based on end user:

• Hospitals
• Clinics
• Orthopedic Surgery Centers

Glenoid Implant Systems Market: Regional Overview

Geographically, the global glenoid implant systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the glenoid implant systems market due to rising obese population. North America is followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a highest rate due to fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Glenoid Implant device markets experienced a slowdown in 2012 in Japan, caused by reimbursement protocols instituted by the Japanese government.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=15236

Glenoid implant Systems Market: Key Players

Some of the major players operating in the market for global Glenoid implant are Smith & Nephew, Stryker, Zimmer, Tornier, Inc., Biomet, Exactech, Lima Corporate, Arthrex, Inc., Integra LifeSciences, DePuy Synthes, while there are a range of other smaller players as well. DePuy Synthes and Tornier represent more than half of the total market size due to its most diversified and innovated portfolios. DePuy and Tornier are expected to be the leading players in the arena for another five years

Hand Hygiene Agents Market: Business Challenges, Emerging Technologies & Competitive Landscape

Hand hygiene means to keep one’s hands clean by washing hands (with soap and water), or disinfecting them with an antiseptic agent, using antiseptic handwash, antiseptic hand rub or surgical hand antisepsis to remove dirt, soil, and microorganism. Antiseptics has been recognized for more than 150 years as the single cost-effective and most prominent means of preventing hospital-acquired infection, as well as for reducing the spread of potential and deadly germs and hence risk of infections from the germs in the society which may lead to hospitalization. It is admissible in all expanse such as workplace, home, and schools. However, the importance of hand hygiene is very high in hospitals or other healthcare related setups.

For Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14099

The Centers for Disease Control and Prevention (CDC), World health organization (WHO) and other leading healthcare organizations has given the specific guidelines and indications for hand hygiene in healthcare. The CDC has estimated that hand hygiene reduces the number around 31% of people getting sick with diarrhea, 58% with weakened immune systems and 16-18% of respiratory illness like cold in the general population. Increase widespread of hand hygiene products will prevent infections and promote the patient's safety. There are different types of hand hygiene methods which include routine hand wash, antiseptic hand wash, antiseptic hand rub and surgical antisepsis. Preventing sickness by maintaining hand hygiene will reduce the antibiotics overuse and can also prevent people from getting sick with the germs which are resistant to antibiotics which can be difficult to treat.

The healthcare-acquired infections (HCAI) prevention and control need is driving the hand hygiene market. While the outbreaks of several infectious diseases like a spread of diarrheal and respiratory illness in many countries offering positive growth for the market. Government initiatives are also contributing to the growth of this market by launching various awareness campaigns and programs such as SAR Hand Hygiene Campaign and SAVE LIVES: Clean Your Hands annual global campaign by WHO, which was focused on patient safety and reducing health care-associated infection.

The Hand Hygiene Agent Market has been segmented on the basis of types of antiseptic agents used for washing hands in different expanses from household to heathcare sector and based on geographical regions. By types of antiseptic agents, the market has been divided into alcohols, chlorhexidine gluconate, iodine and iodophors, and quaternary ammonium compounds. An alcohol-based hand rub must contain at least 60% -95% alcohol for use in a healthcare settings for optimum results. The concentration of chlorhexidine in antiseptic hand wash should be at least 4%, while the maximum number of iodophor preparations in hand hygiene contain 7.5%–10% povidone-iodine. The quaternary ammonium compounds have a slow speed of action and used only in combination with alcohols. Due to the efficiency and the ease of using the alcohol-based hand rubs it is expected to become most popular. The alcohol based antiseptics contributing for the major share in this market, followed by Chlorhexidine and iodine based antiseptics. The rate of healthcare-associated infections was lowered when adherence to recommended hand hygiene practices were improved and antiseptic hand washing was implemented.

On the basis of geographies, the market has been segmented into North America, Europe, Asia-pacific, Latin America, and Middle East & Africa. Because of the high awareness towards hygiene, standard guideline, and proper training to the healthcare professional and general public, North America contributes for the highest share in this market. The Adoption of hand hygiene compliance monitoring (HHCM) devices in hospitals place Europe at the second position. Followed by Asia- Pacific and Rest of the world.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=14099

The key players operating in the hand hygiene agents market are EcoHydra Technologies Ltd, GOJO Industries, Inc., Kutol Products Company, Inc., Deb Group, 3M Co., STERIS Corporation, Win-Medicare etc., are among other significant players worldwide. On the other hand, Kimberly-Clark Meritech are major companies in hygiene monitoring systems.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Pelvic Floor Stimulation Therapy Market: Latest Trends & Insights 2024

Pelvic floor stimulation therapy market: Overview

Pelvic floor stimulation (PFS) therapy is a nonsurgical process that activates the nerves and muscle mechanism of the pelvic floor. PFS therapy is frequently prescribed to strengthen the neuromuscular mechanism of the pelvic floor for the treatment of urinary incontinence. With the help of pelvic floor stimulation therapy, patients suffering from urinary incontinence can regain control over their bladder muscle and the muscles around it.

Pelvic floor stimulation therapy involves controlled electrical or magnetic stimulation with non-implantable stimulators to the nerves of the pelvic floor and bladder. The electrodes are placed around the gonads and the rectum or around the anus. The frequency and amplitude of the stimulating pulses, their duration, the number of treatments per day, and the overall duration of the treatment cycle depend on the type and severity of the incontinence. Pelvic floor stimulation therapy exercises the precise muscles involved in the excretion of urine, no surgery is required, and patient participation is also kept to a minimum.

The report offers a comprehensive evaluation of the market by providing in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions.

Pelvic floor stimulation therapy market: Trends and Drivers

Weakening of the pelvis floor muscles, menopause, obesity, constipation, urinary tract infections, and alcoholism are the main causes of urinary incontinence. The increasing prevalence of these conditions, added to the expanding global geriatric population, is the major driver for the global pelvic floor stimulation therapy market. The increasing healthcare awareness among patients and healthcare professionals in developing countries is also driving the demand from the global pelvic floor stimulation therapy market. On the other hand, the high prices of pelvic floor stimulation devices may hinder the growth of the market in the coming years.

Interpret a Competitive outlook Analysis Report with PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12245

According to the U.S. National Institutes of Health, in 2012, approximately 13 million adult women and 6 million adult males above the age of 40 years were suffering from urinary incontinence in the U.S. alone. UK health data suggests that 4 in 100 adult males and 1 in 5 adult women are suffering from this disorder. As per the Canadian Incontinence Foundation, 3.3 million Canadians above the age of 40 years, equating about 10% of the total population, suffer from some kind of urinary incontinence. This has led to government agencies supporting pelvic floor stimulation therapy, which is likely to lead to better reimbursement options and thus increasing demand in the coming years.

Pelvic floor stimulation therapy market: Segmentation

The global pelvic floor stimulation therapy market can be segmented according to geography and type of stimulator. Geographically, the market for pelvic floor stimulation therapy can be segmented into North American, Europe, Asia Pacific and Rest of the World. Of these, North America holds the highest share in the global market, followed by Europe and Asia Pacific.

On the other hand, the market for pelvic floor stimulation therapy can be segmented into two segments by stimulator type, namely electrical devices and magnetic devices. The electric devices segment accounts for a major share due to the established popularity of these devices among clinicians and patients, whereas magnetic devices were introduced relatively recently and are yet to become popular on a large scale.

Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12245

Pelvic floor stimulation therapy market: Competitive Landscape

There are many companies operating in the global pelvic floor stimulation therapy market, out of which Liberty, Athena, Active Life Technologies, and Mediwatch are the major manufacturers of electrical pelvic floor stimulation devices, while EMD Medical Technologies, MCube Technology and Iskra Medical are the key players in the market for magnetic pelvic floor stimulation devices.